Gene: RNF207
Official Full Name: ring finger protein 207provided by HGNC
Gene Summary: Enables Hsp70 protein binding activity and transmembrane transporter binding activity. Involved in positive regulation of gene expression. Located in perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14460 | RNF207 Knockout cell line (HeLa) | Human | RNF207 | 1:3~1:6 | Negative | Online Inquiry |
KO14461 | RNF207 Knockout cell line (HCT 116) | Human | RNF207 | 1:2~1:4 | Negative | Online Inquiry |
KO14462 | RNF207 Knockout cell line (HEK293) | Human | RNF207 | 1:3~1:6 | Negative | Online Inquiry |
KO14463 | RNF207 Knockout cell line (A549) | Human | RNF207 | 1:3~1:4 | Negative | Online Inquiry |
RNF207 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of RNF207 gene function and its implications in various biological processes and diseases. By utilizing CRISPR-Cas9 technology, these cell lines provide a reliable platform for the targeted disruption of the RNF207 gene, enabling researchers to investigate the resultant phenotypic changes at both molecular and cellular levels.
The primary function of RNF207 Gene Knockout Cell Lines relies on the precise knockout of the RNF207 gene, which encodes a RING finger protein involved in cellular pathways such as protein ubiquitination and regulation of gene expression. The absence of functional RNF207 is crucial for examining its role in mechanisms like cell proliferation, differentiation, and stress responses. Researchers can utilize these knockout models to dissect the molecular underpinnings of various pathologies, including cancer, neurodegenerative diseases, and metabolic disorders.
From a scientific perspective, these cell lines are indispensable in basic research and drug development, providing insights into gene function and potential therapeutic targets. Their applicability spans academic laboratories, biotech firms, and pharmaceutical companies, where understanding gene knockout effects can lead to innovative treatments and interventions.
One significant advantage of RNF207 Gene Knockout Cell Lines is their specificity and ease of use compared to traditional gene silencing methods such as RNA interference (RNAi). The irreversibility of the gene knockout facilitates long-term studies of gene function, while the precise genome editing guarantees reduced off-target effects. This clarity allows researchers to draw more definitive conclusions about the contributions of RNF207 to cellular mechanisms.
Ultimately, the value of RNF207 Gene Knockout Cell Lines lies in their ability to enhance our understanding of gene-disease relationships and contribute to the advancement of therapeutic strategies. Our company, with its dedication to developing high-quality biological products, ensures these cell lines are meticulously validated and characterized to meet the rigorous standards of modern scientific research. By choosing RNF207 Gene Knockout Cell Lines, researchers gain access to a robust tool that can significantly enhance their experimental outcomes and propel their studies forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.